TOP NEWS: GSK, Vir And Eli Lilly To Test Covid-19 Antibody Combination Read More
BROKER RATINGS: Exane Raises Compass But Cuts InterContinental Hotels Read More
TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia Read More
TOP NEWS: Glaxo, Johnson & Johnson Long-Acting HIV Drug Approved In US Read More
LONDON MARKET CLOSE: Stocks Rise As Biden Assumes US Presidency Read More
TOP NEWS: Glaxo And Merck KGaA Discontinue Bintrafusp Alfa Trial Read More
LONDON BROKER RATINGS SUMMARY: BofA And Jefferies Both Cut John Wood Read More
LONDON BRIEFING: Biden To Push US Stimulus Programme As Takes Office Read More
GlaxoSmithKline Presents Positive Efficacy Data Of Dostarlimab Read More
UK BROKER RATINGS SUMMARY: JPMorgan Raises Derwent, Cuts Shaftesbury Read More
LONDON BRIEFING: Resilient UK Economy May Avoid Double-Dip Recession Read More
Glaxo, Pfizer's ViiV Gets EU Approval For Tivicay In Children With HIV Read More
Vectura Forecasts 2020 Earnings To Top Board Expectations Read More
TOP NEWS: GSK, Vir To Probe Second Virus Antibody In NHS-Backed Trial Read More
UK Dividends Calendar - Next 7 Days Read More
UK DIRECTOR DEALINGS SUMMARY: Rio Tinto Copper & Diamonds Chief Sells Read More
Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation Read More
TOP NEWS: Glaxo Receives EU Marketing Authorisation For HIV Treatment Read More
LONDON MARKET PRE-OPEN: Frasers Pulls Guidance Amid Fresh Restrictions Read More
